Investor World Review
SEE OTHER BRANDS

The latest news on finance and banking

Investor World Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Investor World Review.

Press releases published on May 23, 2025

MINT Income Fund Announces Normal Course Issuer Bid

MINT Income Fund Announces Normal Course Issuer Bid

TORONTO, May 23, 2025 (GLOBE NEWSWIRE) -- MINT Income Fund (the “Fund”) (TSX: MID.UN) announced that it has filed a notice with the Toronto Stock Exchange (the “TSX”) and received its approval to make a normal course issuer bid (“NCIB”). Purchases pursuant …

Clip Money Inc. Reports First Quarter 2025 Results

Clip Money Inc. Reports First Quarter 2025 Results

TORONTO, May 23, 2025 (GLOBE NEWSWIRE) -- Clip Money Inc. (TSX-V: CLIP) (OTCQB: CLPMF) (“Clip Money” or the “Company”), a company that operates a multi-bank self-service deposit system for businesses, is pleased to announce its financial results for the …

Tilray Medical bringt die bekannte kanadische Cannabismarke Good Supply nach Deutschland

Tilray Medical bringt die bekannte kanadische Cannabismarke Good Supply nach Deutschland

NEUMÜNSTER, Deutschland, May 23, 2025 (GLOBE NEWSWIRE) -- Tilray Medical („Tilray“), ein Geschäftsbereich von Tilray Brands, Inc. (NASDAQ: TLRY und TSX: TLRY) und ein weltweit führendes Unternehmen im Bereich des medizinischen Cannabis, das die …

Tilray Medical introduit Good Supply, la marque emblématique de cannabis canadienne, en Allemagne

Tilray Medical introduit Good Supply, la marque emblématique de cannabis canadienne, en Allemagne

NEUMÜNSTER, Allemagne, 23 mai 2025 (GLOBE NEWSWIRE) -- Tilray Medical (« Tilray »), une division de Tilray Brands, Inc. (NASDAQ : TLRY et TSX : TLRY) et un leader mondial du cannabis thérapeutique qui permet aux patients et aux professionnels de santé de …

Autolus Therapeutics Announces Positive CHMP Opinion for Obecabtagene Autoleucel for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)

Autolus Therapeutics Announces Positive CHMP Opinion for Obecabtagene Autoleucel for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)

Positive CHMP opinion based on FELIX clinical trial of obecabtagene autoleucel (obe-cel) in adult patients with r/r B-ALL, demonstrating high and durable response rates and low toxicity Opinion follows FDA approval and MHRA conditional marketing …

Elko County’s Latest Virtual Tax Sale on Bid4Assets Results in Nearly 200 Properties Sold

Elko County’s Latest Virtual Tax Sale on Bid4Assets Results in Nearly 200 Properties Sold

ELKO, Nev., May 23, 2025 (GLOBE NEWSWIRE) -- The Elko County, NV Treasurer-Tax Collector’s office conducted the county’s latest virtual tax foreclosure sale with Bid4Assets, a leading online auction marketplace for distressed real estate sales. The sale, …

Open Gear Lubricants Market worth $907.9 million by 2030, at 3.5%, says MarketsandMarkets™

Open Gear Lubricants Market worth $907.9 million by 2030, at 3.5%, says MarketsandMarkets™

Delray Beach, FL, May 23, 2025 (GLOBE NEWSWIRE) -- In terms of value, the Open Gear Lubricants Market  open gear lubricants market size was USD 738.1 million in 2024 and is projected to reach 907.9 million by 2030, at a CAGR of 3.5%, between 2024 and 2030, …

Martinrea International Inc. Announces TSX Approval of Normal Course Issuer Bid

Martinrea International Inc. Announces TSX Approval of Normal Course Issuer Bid

TORONTO, May 23, 2025 (GLOBE NEWSWIRE) -- Martinrea International Inc. (TSX: MRE) (“Martinrea” or the “Company”), today announced that it has filed with the Toronto Stock Exchange (the “TSX”), and the TSX has accepted, its notice of intention to make a …

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., May 23, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today …

Hola Prime Plans to Enter Futures Trading to Solve One of Finance’s Most Persistent Problems: Complexity

Hola Prime Plans to Enter Futures Trading to Solve One of Finance’s Most Persistent Problems: Complexity

NEW YORK, NY, May 23, 2025 (GLOBE NEWSWIRE) -- Hola Prime, a leading proprietary trading firm, has announced its expansion into futures trading with a clear and ambitious goal: to simplify one of the most complicated and inaccessible segments of the …

Bybit Launches Global P2P School to Advance Peer-to-Peer Trading Education

Bybit Launches Global P2P School to Advance Peer-to-Peer Trading Education

Dubai, UAE, May 23rd, 2025, Chainwire Bybit, the world’s second-largest cryptocurrency exchange by trading volume, has launched Bybit P2P School, a first-of-its-kind global initiative designed to reshape peer-to-peer trading education. The program …

Charleswood Limited Navigates Shifting Market Dynamics with Strategic Focus

Charleswood Limited Navigates Shifting Market Dynamics with Strategic Focus

HONG KONG, May 23, 2025 (GLOBE NEWSWIRE) -- Charleswood Limited today released a market commentary in light of the latest financial developments, highlighting both risk and opportunity amid shifting macroeconomic signals. Global markets remain broadly …

VTRS FRAUD ALERT: Lose Money when Viatris Inc. Stock Dropped 15%? Contact BFA Law by June 3 Class Action Deadline (NASDAQ:VTRS)

VTRS FRAUD ALERT: Lose Money when Viatris Inc. Stock Dropped 15%? Contact BFA Law by June 3 Class Action Deadline (NASDAQ:VTRS)

NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

IMUNON Announces 2025 ASCO Annual Meeting Oral Presentation Highlighting Unprecedented Survival Data from Phase 2 Trial of IMNN-001 in Treatment of Newly Diagnosed Advanced Ovarian Cancer

IMUNON Announces 2025 ASCO Annual Meeting Oral Presentation Highlighting Unprecedented Survival Data from Phase 2 Trial of IMNN-001 in Treatment of Newly Diagnosed Advanced Ovarian Cancer

Data show continuous clinically significant improvement, with median 13-month and 3-month increases in overall and progression-free survival, respectively, in treatment group Women treated with IMNN-001 and standard of care chemotherapy plus PARP …

FRO - Q1 2025 Presentation

FRO - Q1 2025 Presentation

Please find enclosed the presentation of Frontline plc´s first quarter 2025 results to be held on the webcast / conference call 23 May, 2025 at 15:00 CET. This information is subject to the disclosure requirements pursuant to section 5 – 12 of the …

Evaxion to announce business update and first quarter 2025 financial results on May 27, 2025

Evaxion to announce business update and first quarter 2025 financial results on May 27, 2025

COPENHAGEN, Denmark, May 23, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its first quarter 2025 financial results on …

GCL to Participate in Maxim Group’s 2025 Virtual Tech Investor Conference: Discover the Innovations Reshaping Tomorrow

GCL to Participate in Maxim Group’s 2025 Virtual Tech Investor Conference: Discover the Innovations Reshaping Tomorrow

SINGAPORE, May 23, 2025 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd. (NASDAQ: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced that the Company will be participating in an upcoming investor conference. Maxim …

Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025

Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025

SAN DIEGO, May 23, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company management will participate in the Jefferies Global Healthcare Conference, taking place June 3-5, 2025 in New York, NY. Jefferies …

Safe Shot to Capitalize on Yerbae’s Strong Retail Presence & Distributor Network Following Acquisition

Safe Shot to Capitalize on Yerbae’s Strong Retail Presence & Distributor Network Following Acquisition

Acquisition expected to increase Safety Shot annual revenue by 1000 percent over 2024 SCOTTSDALE, Ariz., May 23, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“SHOT”, "Safety Shot”, or the “Company”), a wellness and dietary supplement company, …

SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN

SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN

– If approved, mirdametinib is expected to be the first and only therapy in the European Union with marketing authorization for both adults and children with NF1-PN – – Decision from European Commission expected in the third quarter of 2025 – STAMFORD, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service